Today: 5 June 2026
BigBear.ai (BBAI) Stock’s Wild Ride: Palantir Shock, Defense AI Deals & 2025 Outlook
13 November 2025
3 mins read

BigBear.ai (BBAI) soars on Nov. 13 as two-day AI‑defense rally extends; fresh analyst note trims price target despite momentum

Updated November 13, 2025 — Midday

Summary: BigBear.ai stock is rallying again today, extending gains kicked off earlier this week by Q3 results and a $250 million deal to buy Ask Sage. As of 12:04 UTC, shares trade at $7.17, up about 18.4% from yesterday’s close. At the same time, a new note this morning trimmed BBAI’s price target, underscoring how divided the Street remains on the name.


What’s new today (Nov. 13, 2025)

  • Live price action: BBAI changes hands around $7.17 (+18.4%) midday, adding to Wednesday’s surge. Volatility remains elevated after earnings and M&A headlines earlier in the week.
  • Fresh analyst signal: A TipRanks write‑up today says its AI Analyst cut the BBAI price target to $5.50 (from $6.00) and kept a Neutral stance following the Q3 print and Ask Sage acquisition. The note cites declining year‑over‑year revenue but better‑than‑expected EPS as reasons for caution.
  • Ongoing media coverage of the rally: Coverage overnight and into this morning highlights that Tuesday/Wednesday’s pop was catalyzed by the Ask Sage buy and an earnings beat, with the move still in focus today as traders reassess the AI‑defense narrative.

Why the stock is moving

1) M&A catalyst — $250M Ask Sage deal.
On Monday after the bell, BigBear.ai announced a definitive agreement to acquire Ask Sage—a generative‑AI platform built for defense and other regulated users—for $250 million. Management says Ask Sage supports 100,000+ users and could deliver ~$25 million ARR in 2025. BigBear.ai expects the deal to close late Q4 2025 or early Q1 2026. The transaction has sharpened investor focus on BBAI’s mission‑ready AI for national security, a theme that has been bid up across the defense/AI complex this year.

2) Earnings beat with mixed internals.
For Q3 2025, BigBear.ai reported revenue of $33.1 million (‑20% y/y) but above consensus, and recorded GAAP net income of $2.5 million. Non‑GAAP adjusted EBITDA was ‑$9.4 million as the company continued to invest in growth. Management reaffirmed 2025 revenue guidance at $125–$140 million and flagged a record cash balance of $456.6 million at quarter‑end. The company also listed backlog at $376 million as of Sept. 30. Those headlines helped ignite the two‑day run investors are extending into today.

3) Street still split — one target up, one down.
This week brought conflicting takes: Cantor Fitzgerald lifted its price target to $7 while maintaining Overweight, arguing the strategy strengthens BBAI’s defense AI positioning; meanwhile, today’s TipRanks note trimmed its target to $5.50 and stayed Neutral. That push‑and‑pull is keeping volatility high as the market weighs near‑term execution risks against longer‑term government/defense AI demand.


Today’s tape in context

  • Media lens: Barron’s framed the surge as investors rewarding a better‑than‑expected EPS print and the Ask Sage expansion into defense GenAI; it also cautioned that long‑term profitability remains a key debate. That backdrop is the one traders are carrying into today’s session.
  • Company fundamentals at a glance: Despite the beat, management acknowledged year‑over‑year revenue pressure tied to lower volume on certain Army programs, and adjusted EBITDA remains negative as the firm invests. Cash and backlog metrics offer runway if deal integration proceeds on plan.

Key numbers investors are watching today

  • Share price (intraday):$7.17 (12:04 UTC), +18.4% vs. prior close.
  • Deal size:$250 million Ask Sage acquisition; expected close late Q4 2025/early Q1 2026.
  • Q3 revenue:$33.1 million (‑20% y/y), above Street expectations; GAAP net income:$2.5 million; Adjusted EBITDA:‑$9.4 million.
  • FY2025 outlook (unchanged):$125–$140 million in revenue.

What to watch next

  1. Deal close & integration: Look for regulatory and closing updates on Ask Sage and early breadcrumbs on how the platform will be bundled with BigBear.ai’s software and services. Management has signaled minimal contribution to FY25, so attention turns to 2026 revenue/ARR uplift.
  2. Contract cadence: Revenue slippage tied to U.S. Army program timing was a drag in Q3; any new awards or task orders that refill near‑term delivery could change sentiment quickly.
  3. Street revisions: With one PT increase and one PT cut already this week, additional analyst models could sway near‑term direction and implied fair value.

Bottom line for Nov. 13

BigBear.ai is up sharply again today, riding momentum from an earnings beat and a defense‑focused GenAI acquisition. The bull case centers on defense AI tailwinds, a stronger cash position, and a bigger platform via Ask Sage. The bear case focuses on year‑over‑year revenue declines, negative adjusted EBITDA, and execution risk on government program timing and M&A integration. Today’s split analyst commentary captures that tension—even as the tape favors the bulls.


Disclosure: This article is for informational purposes only and does not constitute investment advice. All prices are intraday and subject to change.

Stock Market Today

  • Stocks Slide as AI Rally Pauses Amid US-Iran Peace Talk Stalemate
    June 4, 2026, 10:25 PM EDT. Asian share markets fell on Friday as investors took profits in technology stocks after a period of gains driven by artificial intelligence (AI). Traders grew cautious ahead of the weekend, shifting to defensive positions amid rising tensions in the Middle East. The pause in the US-Iran peace negotiations has added to market jitters, contributing to the cautious mood. The combination of profit-taking in tech and geopolitical uncertainty pressured stocks lower, highlighting investors' sensitivity to both sector-specific momentum and broader international developments.

Latest articles

Dow Hits Record, But Wall Street Watches After-Hours Session

Dow Hits Record, But Wall Street Watches After-Hours Session

5 June 2026
Dow soared to a record close, but after-hours jitters hit as Broadcom missed revenue expectations and cut its AI-chip forecast, dragging chip stocks and exposing markets to Friday’s key jobs report, which could sway rates, yields, and tech valuations. Lululemon shares plunged 11% after slashing its profit outlook.
AT&T Stock Drops, Investors Eye SpaceX’s Move

AT&T Stock Drops, Investors Eye SpaceX’s Move

5 June 2026
AT&T shares plunged 3.3% to $22.77 after a Supreme Court loss and an Oppenheimer downgrade citing rising satellite broadband competition, as SpaceX’s $75 billion IPO nears; investors fear AT&T’s fiber-heavy strategy faces new risks, with Oppenheimer warning broadband and mobile growth could be at risk from low Earth orbit rivals.
Marvell rises as chip peers drop, Wall Street eyes index move

Marvell rises as chip peers drop, Wall Street eyes index move

5 June 2026
Marvell jumped 4.9% to $316.43, defying a chip selloff, as traders bet on S&P 500 inclusion and Nvidia-linked AI demand; the stock later slipped to $305.18 after hours, with volume more than double average, as investors await Friday’s S&P announcement and weigh risks of high expectations and index flows.
Guidewire Beats Earnings but Shares Drop on Revenue Number

Guidewire Beats Earnings but Shares Drop on Revenue Number

5 June 2026
Guidewire Software plunged 13.77% after hours to $130.36 as investors fixated on annual recurring revenue guidance that missed Wall Street’s target by a narrow margin, overshadowing strong earnings and revenue beats; the stock’s sharp drop highlights concerns over contract growth pacing despite raised full-year outlooks and robust financials.
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?
Previous Story

Rolls‑Royce Share Price Today (13 Nov 2025): RR.L edges lower after in‑line trading update as guidance held and flying hours rise

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?
Next Story

Pfizer Stock Today, November 13, 2025: BioNTech Stake Sale, Metsera Deal and a 6%+ Dividend Put PFE Back in Focus

Go toTop